EDCTP and CEPI funding moves IAVI's Lassa fever vaccine candidate into advanced clinical development
4 Mins read
Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO…